Substance use disorders before and after liver transplantation
Jason L. Eccleston, Michael R. Lucey – 31 October 2017
Normothermic machine perfusion of the liver
Hynek Mergental, Garrett R. Roll – 31 October 2017
Nonsurgical options for localized hepatocellular carcinoma
John Ha, Robert J. Wong – 31 October 2017
HCV treatment in patients with decompensated liver disease
Elizabeth C. Verna – 31 October 2017
Controversies in hepatitis C therapy: Reactivation of hepatitis B virus
Sarah R. Lieber, Michael W. Fried – 31 October 2017
Nonsurgical options for localized hepatocellular carcinoma
John Ha, Robert J. Wong – 31 October 2017
More is less: Calling for joining forces for rare pediatric liver tumors research
Jean de Ville de Goyet, Bruce Morland, Piotr Czauderna – 31 October 2017
HCV treatment in patients with decompensated liver disease
Elizabeth C. Verna – 31 October 2017
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
Puneet Puri, Suthat Liangpunsakul, Jeffrey E. Christensen, Vijay H. Shah, Patrick S. Kamath, Gregory J. Gores, Susan Walker, Megan Comerford, Barry Katz, Andrew Borst, Qigui Yu, Divya P. Kumar, Faridoddin Mirshahi, Svetlana Radaeva, Naga P. Chalasani, David W. Crabb, Arun J. Sanyal, for the TREAT Consortium – 30 October 2017 – Intestinal dysbiosis is implicated in alcoholic hepatitis (AH). However, changes in the circulating microbiome, its association with the presence and severity of AH, and its functional relevance in AH is unknown.
Circulating bugs in blood in alcoholic liver disease!
Gabriel Perlemuter – 30 October 2017